New Technology– category –
-
University of Queensland Develops Scalable Engineered Extracellular Vesicles for Enhanced Targeted Delivery to Ovarian Cancer
Medical Xpress (University of Queensland) Australia Overview Researchers at the University of Queensland have developed scalable engineered extracellular vesicles (EVs) capable of targeted molecular cargo delivery to ovarian tumors. This... -
Converging 3D Bioprinting with Organoid Technology Accelerates Precision Medicine and Tissue Engineering
Oxford Academic (Regenerative Biomaterials) UK Overview A recent review highlights the transformative potential of integrating 3D bioprinting with organoid technology, opening new avenues for personalized medicine and advanced tissue eng... -
Precision Gene Editing with Adenine Base Editors Restores Muscle Function in Childhood FSHD Model, Advancing Gene Therapy
bioRxiv Australia Overview This study presents a novel therapeutic strategy for childhood-onset Facioscapulohumeral Muscular Dystrophy (FSHD), an intractable genetic disorder. Researchers leveraged an iPSC-derived skeletal muscle model t... -
MIT Engineers Vascular Networks with Mechanical Strain, Overcoming Key Barrier in Artificial Organ Development
Massachusetts Institute of Technology (MIT) USA Overview Researchers at MIT have pioneered a novel method to precisely control the growth of vascular networks by mechanically stretching cells, a critical breakthrough for artificial organ... -
iPSC-Derived Microglia-like Cells Reveal Protocol-Specific Transcriptomes and Potent Glioma Phagocytosis, Advancing Brain Tumor Research
bioRxiv USA Overview Human induced pluripotent stem cell (iPSC)-derived microglia-like cells (iMG) are emerging as critical tools for understanding human microglia function and the brain tumor microenvironment. A comprehensive study anal... -
CRISPR Gene Editing Technology Drives Clinical Adoption: FDA’s First Approval, Casgevy, for Sickle Cell Disease and Beta Thalassemia Accelerates Clinical Translation
Britannica Global Overview CRISPR, a powerful gene-editing tool with high sequence specificity, precisely removes or inserts DNA at specific genomic locations, offering superior efficiency, reliability, and cost-effectiveness over tradit... -
Hopstem’s iPSC-Derived Neural Progenitor Cell hNPC01 Receives FDA IND Clearance and Fast Track Designation for Stroke and Traumatic Brain Injury
AllSci USA Overview Hopstem Biotechnology announced that its allogeneic iPSC-derived forebrain neural progenitor cell therapy, hNPC01, received both IND clearance and Fast Track designation from the U.S. FDA for treating chronic motor de... -
AI Unlocks CAR T Durability: Single-Cell Models Predict Lasting Remission, Identify Novel Biomarker in B-ALL
bioRxiv USA Overview While CD19-targeted CAR T-cell therapy offers significant hope for B-cell Acute Lymphoblastic Leukemia (B-ALL) patients, approximately half experience relapse within a year. A new study demonstrates that single-cell ... -
4D Printing and Smart Hydrogels Revolutionize Regenerative Wound Therapy: Vascularized Scaffolds Enable Precision Drug Delivery
Polymers (PMC) Global Overview New paradigms are emerging in precision drug delivery and regenerative wound therapy, spanning from smart hydrogel design to 4D-printed scaffolds. Advances in 3D bioprinting now enable the fabrication of va... -
Advanced CAR-T/NK Therapies for Solid Tumors: iPSC-Derived CAR-NK Cells Show Promise in Efficacy and Safety
Oncodaily Global Overview In solid tumor treatment, IL-15 armed GPC3 CAR-T cells demonstrated promising early data, with cytokine release syndrome (CRS) managed by an inducible caspase-9 switch. Notably, iPSC-derived IL-15 incorporated C...
